Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shugan Jianwei Pills (also known as Shugan Jianwei Wan) are a traditional Chinese medicine (TCM) herbal formulation widely used in China to treat gastrointestinal and digestive disorders. The formulation is composed of a complex mixture of fifteen herbal ingredients, including *Magnolia officinalis* (ginger-prepared), *Cyperus rotundus* (vinegar-prepared), *Paeonia lactiflora* (white peony root), *Bupleurum chinense*, *Citrus reticulata* (tangerine peel and green peel), and *Corydalis yanhusuo*, among others. It is primarily indicated for the treatment of liver-stomach disharmony, which manifests as epigastric distension and pain, chest and hypochondriac fullness, vomiting, acid regurgitation, abdominal distension, and constipation. Shugan Jianwei Pills function by soothing the liver, regulating qi, strengthening the spleen, and harmonizing the stomach. The product is manufactured by several pharmaceutical companies in China, including Shanxi Huakang Pharmaceutical and Beijing Tongrentang, and is available as oral water pills.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shugan Jianwei Pills.